U.S. market Closed. Opens in 7 hours 44 minutes

CRBU | Caribou Biosciences, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 2.0600 - 2.4000
52 Week Range 1.5000 - 8.33
Beta 2.27
Implied Volatility 121.37%
IV Rank 33.46%
Day's Volume 2,424,537
Average Volume 945,323
Shares Outstanding 90,362,800
Market Cap 211,448,952
Sector Healthcare
Industry Biotechnology
IPO Date 2021-07-23
Valuation
Profitability
Growth
Health
P/E Ratio -1.77
Forward P/E Ratio N/A
EPS -1.32
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 158
Country USA
Website CRBU
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma; and CB-011, an allogeneic anti-BCMA CAR-T cell therapy for the treatment of relapsed or refractory multiple myeloma. The company also develops CB-012, an allogeneic anti-CD371 CAR-T cell therapy for the treatment of relapsed or refractory acute myeloid leukemia; and CB-020, an allogeneic CAR-NK cell therapy for the treatment of solid tumors. It has collaboration with AbbVie Manufacturing Management Unlimited Company to develop CAR-T cell therapies. The company was incorporated in 2011 and is headquartered in Berkeley, California.
CRBU's peers: ABSI, ADMA, ADPT, ALLK, ALLO, ARCT, ATRA, BEAM, CGEN, NTLA, EDIT, CRSP, VERV, FATE, PRME, SANA, NAUT, QSI, VRTX
*Chart delayed
Analyzing fundamentals for CRBU we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is weak. For more detailed analysis please see CRBU Fundamentals page.

Watching at CRBU technicals we can see that long-term trend is bearish, while middle-term trend is bullish, as well as bullish short-term trend. More technicals details can be found on CRBU Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙